1. Home
  2. DELL vs AZN Comparison

DELL vs AZN Comparison

Compare DELL & AZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dell Technologies Inc.

DELL

Dell Technologies Inc.

N/A

Current Price

$540.52

Market Cap

261.9B

Sector

Technology

ML Signal

N/A

Logo AstraZeneca PLC

AZN

AstraZeneca PLC

N/A

Current Price

$157.90

Market Cap

250.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DELL
AZN
Founded
1984
1992
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Computer Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
261.9B
250.7B
IPO Year
2013
1995

Fundamental Metrics

Financial Performance
Metric
DELL
AZN
Price
$540.52
$157.90
Analyst Decision
Buy
Strong Buy
Analyst Count
29
11
Target Price
★ $579.36
$212.17
AVG Volume (30 Days)
★ 8.6M
2.6M
Earning Date
09-01-2026
10-30-2026
Dividend Yield
0.47%
★ 2.00%
EPS Growth
★ 36.05
N/A
EPS
★ 11.58
N/A
Revenue
★ $113,538,000,000.00
N/A
Revenue This Year
$70.44
$7.54
Revenue Next Year
$15.76
$6.09
P/E Ratio
$47.37
★ $31.91
Revenue Growth
★ 18.80
N/A
52 Week Low
$110.22
$80.48
52 Week High
$595.51
$212.71

Technical Indicators

Market Signals
Indicator
DELL
AZN
Relative Strength Index (RSI) 53.41 43.70
Support Level $530.45 $154.89
Resistance Level $595.51 $169.77
Average True Range (ATR) 22.54 2.62
MACD -5.74 -0.20
Stochastic Oscillator 17.41 6.49

Price Performance

Historical Comparison
DELL
AZN

About DELL Dell Technologies Inc.

Dell Technologies is a broad information technology vendor, primarily supplying hardware to enterprises. It focuses on premium and commercial personal computers, as well as enterprise on-premises data center hardware. It holds top-three shares in its core markets of personal computers, peripheral displays, mainstream servers, and external storage. Dell has a robust ecosystem of component and assembly partners and also relies heavily on channel partners to fulfill its sales.

About AZN AstraZeneca PLC

A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.

Share on Social Networks: